Category: News WellSyndicate content

Content tagged to appear in the middle column of the home page

Intuitive Surgical's Q1 sales, earnings miss the mark

April 21, 2015 by Brad Perriello

Intuitive Surgical's 1st-quarter sales and earnings results fall short of expectations.

Intuitive Surgical's Q1 sales, earnings miss the mark

MassDevice.com +3 | The top 3 medtech stories for April 21, 2015

April 21, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Cochlear Ltd. wins reprieve in $131m patent loss to Advanced Bionics

April 21, 2015 by Brad Perriello

Cochlear Ltd. wins a new damages trial in its $131 million patent infringement loss to Advanced Bionics.

Cochlear Ltd. wins reprieve in $131m patent loss to Advanced Bionics

InPress Technologies closes trial of postpartum hemorrhage device

April 21, 2015 by Mark Hollmer

InPress Technologies successfully closes a 1st-in-human trial of its disposable device for treating postpartum hemorrhage.

InPress Technologies closes trial of postpartum hemorrhage device

It took less than 9 months for InPress Technologies to fund and successfully conclude a 1st-in-human trial of its disposable device for treating postpartum hemorrhage, co-founder & CEO Jessie Becker said last week.

Arthrex loses another appeal bid in $35m loss to KFx

April 21, 2015 by Mark Hollmer

Arthrex loses another appeal bid in its $35 million patent infringement loss to KFx Medical.

Arthrex loses another appeal bid in $35m loss to KFx

Arthrex lost another bid for an appeal of its $35 million patent infringement loss to orthopedics rival KFx Medical when a federal appeals court declined to revisit the case.

Sunshine Heart can resume trial after FDA OKs 'minor' changes

April 21, 2015 by Brad Perriello

Sunshine Heart said the FDA will let it resume a clinical trial of its C-Pulse heart failure device after 'minor' protocol changes, following a pause initiated last month after 4 patients died.

Sunshine Heart can resume trial after 'minor' changes